Axiolabs Arimiplex contains Anastrozole in oral tablet form, formulated at 1 mg per tablet. For low-dose compounds such as Anastrozole, precise dosing is especially important, making independent lab testing a key factor in verifying product quality.
Below is the latest available lab test confirming the potency of Arimiplex 1 mg, conducted by a trusted third-party laboratory.
Latest Lab Result (2026)
Janoshik Lab Report – 2026-03-23
- Product: Arimiplex
- Active Substance: Anastrozole
- Manufacturer: Axiolabs
- Labeled Dosage: 1 mg/tablet
- Result: 1.09 mg/tablet
- Laboratory: Janoshik
This lab test shows a measured content of 1.09 mg per tablet, slightly above the labeled 1 mg dosage. This result indicates accurate formulation with a small positive variance.
Potency Analysis
- Labeled dosage: 1 mg
- Measured dosage: 1.09 mg
- Deviation: ~+9%
- Laboratory: Janoshik
The measured result shows a slight overfill, which is commonly used in pharmaceutical tablet manufacturing to ensure that the product consistently meets its labeled dosage.
About Arimiplex (Anastrozole)
Anastrozole is an aromatase inhibitor commonly used in oral tablet formulations requiring precise dosing. Due to the low milligram strength, even small variations can be significant, making accurate manufacturing and verification especially important.
Independent lab testing helps confirm that each tablet delivers a dosage close to its labeled amount and provides transparency regarding product quality.
Conclusion
The available lab test for Axiolabs Arimiplex 1 mg shows a measured dosage of 1.09 mg per tablet, slightly exceeding the labeled amount. This result indicates accurate formulation with a controlled positive variance.
As a newly tested product, additional lab reports over time will provide further insight into long-term batch consistency.
Frequently Asked Questions
Yes, the lab test shows a measured dosage of 1.09 mg per tablet, slightly above the labeled 1 mg.
Yes, small variations can occur in tablet manufacturing, and slight overfill is often used to ensure minimum labeled potency.
The available report was conducted by Janoshik, an independent laboratory.
Currently, only one lab test is available. Additional reports may provide more insight into consistency across batches.
